<?xml version="1.0" encoding="UTF-8"?>
<feed xmlns="http://www.w3.org/2005/Atom">
  <id>https://recalls.watch/feed/substance-isotretinoin.xml</id>
  <title>Recalls Watch: Isotretinoin</title>
  <link rel="self" href="https://recalls.watch/feed/substance-isotretinoin.xml"/>
  <link href="https://recalls.watch/alerts/"/>
  <updated>2026-04-29T00:00:00Z</updated>
  <entry>
    <id>https://recalls.watch/recall/fda/98730/</id>
    <title>Teva Pharmaceuticals USA, Inc: Claravis</title>
    <link href="https://recalls.watch/recall/fda/98730/"/>
    <updated>2026-04-29T12:00:00Z</updated>
    <category term="drugs"/>
    <summary>FDA: Failed Impurities/Degradation Specifications: Out of specification for specific impurity Tretinoin</summary>
  </entry>
  <entry>
    <id>https://recalls.watch/recall/fda/98275/</id>
    <title>Teva Pharmaceuticals USA, Inc: Isotretinoin Capsules and 1 more</title>
    <link href="https://recalls.watch/recall/fda/98275/"/>
    <updated>2026-04-15T12:00:00Z</updated>
    <category term="drugs"/>
    <summary>FDA: Superpotent and Subpotent</summary>
  </entry>
  <entry>
    <id>https://recalls.watch/recall/fda/98477/</id>
    <title>MYLAN PHARMACEUTICALS INC: Amnesteem</title>
    <link href="https://recalls.watch/recall/fda/98477/"/>
    <updated>2026-03-11T12:00:00Z</updated>
    <category term="drugs"/>
    <summary>FDA: Failed Dissolution Specifications</summary>
  </entry>
  <entry>
    <id>https://recalls.watch/recall/fda/94294/</id>
    <title>Teva Pharmaceuticals USA, Inc: Isotretinoin Capsules</title>
    <link href="https://www.accessdata.fda.gov/scripts/ires/index.cfm?Event=94294"/>
    <updated>2024-04-17T12:00:00Z</updated>
    <category term="drugs"/>
    <summary>FDA: Superpotent Drug: The 3-month stability result for assay was found to be above specification limit</summary>
  </entry>
</feed>
